Tissue concentrations of vancomycin and Moxifloxacin in periprosthetic infection in rats

Acta Orthopaedica

Volumn 78, Issue 6, 2007, Pages 766-773

  Beckmann, Johannes ^a   Kees, Frieder ^a   Schaumburger, Jens ^a   Kalteis, Thomas ^a   Lehn, Norbert ^a   Grifka, Joachim ^a   Lerch, Klaus ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Orthopedic Surgery and Traumatology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HINDLIMB; MALE; NONHUMAN; PROSTHESIS INFECTION; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; MALE; OSTEOMYELITIS; PROSTHESIS-RELATED INFECTIONS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; TREATMENT OUTCOME; VANCOMYCIN;

EID: 38749124374     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670710014536     Document Type: Article

References (41)

1. Arens S, Schlegel U, Printzen G, Ziegler W J, Perren S M, Hansis M. Influence of materials for fixation implants on local infection. An experimental study of steel versus titanium DCP in rabbits. J Bone Joint Surg (Br) 1996; 78: 647-51.
2. Backes D W, Aboleneen H I, Simpson J A. Quantitation of vancomycin and its crystalline degradation product (CDP-1) in human serum by high performance liquid chromatography. J Pharm Biomed Anal 1998; 16: 1281-7.
3. Bearden D T, Rodvold K A. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics. Clin Pharmacokinet 2000; 38: 415-26.
4. Blaser J, Vergeres P, Widmer A F, Zimmerli W. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother 1995; 39: 1134-9.
5. Blouin R A, Bauer L A, Miller D D, Record K E, Griffen W O, Jr. Vancomycin pharmacokinetics in normal and morbidly obese subjects. Antimicrob Agents Chemother 1982; 21: 575-80.
6. Breilh D, Jougon J, Djabarouti S, Gordien J B, Xuereb F, Velly J F, Arvis P, Landreau V, Saux M C. Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state. J Chemother 2003; 15: 558-62.
7. Catherall E J, Gillon V, Hurn S, Irwin R, Mizen L. Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats. Antimicrob Agents Chemother 1992; 36: 458-62.
8. Dalhoff A. Pharmacodynamics of fluoroquinolones. J Antimicrob Chemother 1999 (43 Suppl B): 51-9.
9. Dalhoff A, Schmitz F J. In vitro antibacterial activity and pharmacodynamics of new quinolones. Eur J Clin Microbiol Infect Dis 2003; 22: 203-21.
10. Della Valle C J, Scher D M, Kim Y H, Oxley C M, Desai P, Zuckerman J D, Di Cesare P E. The role of intraoperative Gram stain in revision total joint arthroplasty. J Arthroplasty 1999; 14: 500-4.
11. Drobny T K, Munzinger U. Problems of infected knee prosthesis. Orthopade 1991; 20: 239-43.
12. Eveillard M, Mertl P, Canarelli B, Lavenne J, Fave M H, Eb F, Vives P. Risk of deep infection in first-intention total hip replacement. Evaluation concerning a continuous series of 790 cases. Presse Med 2001; 30: 1868-75.
13. Farin D, Piva G A, Gozlan I, Kitzes-Cohen R. A modified HPLC method for the determination of vancomycin in plasma and tissues and comparison to FPIA (TDX). J Pharm Biomed Anal 1998; 18: 367-72.
14. Gracia E, Lacleriga A, Monzon M, Leiva J, Oteiza C, Amorena B. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms. J Surg Res 1998; 79: 146-53.
15. Graziani A L, Lawson L A, Gibson G A, Steinberg M A, MacGregor R R. Vancomycin concentrations in infected and noninfected human bone. Antimicrob Agents Chemother 1988; 32: 1320-2.
16. Haleem A A, Rouse M S, Lewallen D G, Hanssen A D, Steckelberg J M, Patel R. Gentamicin and vancomycin do not impair experimental fracture healing. Clin Orthop 2004; (427): 22-4.
17. Hoogkamp-Korstanje J A, Roelofs-Willemse J. Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates. J Antimicrob Chemother 2000; 45: 31-9.
18. Ince D, Zhang X, Hooper D C. Activity of and resistance to moxifloxacin in Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47: 1410-5.
19. Isiklar Z U, Demirors H, Akpinar S, Tandogan R N, Alparslan M. Two-stage treatment of chronic staphylococcal orthopaedic implant-related infections using vancomycin impregnated PMMA spacer and rifampin containing antibiotic protocol. Bull Hosp Jt Dis 1999; 58: 79-85.
20. Kaatz G W, Moudgal V V, Seo S M. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. J Antimicrob Chemother 2002; 50: 833-8.
21. Kalteis T, Beckmann J, Schroder H J, Handel M, Grifka J, Lehn N, Lerch K. Moxifloxacin superior to vancomycin for treatment of bone infections - a study in rats. Acta Orthop Scand 2006; 77: 315-9.
22. Kees F, Naber K G, Schumacher H, Grobecker H. Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue. Chemotherapy 1988; 34: 437-43.
23. Kordelle J, Frommelt L, Kluber D, Seemann K. [Results of one-stage endoprosthesis revision in periprosthetic infection cause by methicillin-resistant Staphylococcus aureus]. Ergebnisse einzeitiger Endoprothesenwechsel bei periprothetischer Infektion durch einen methicillinresistenten Staphylococcus aureus (MRSA). Z Orthop Ihre Grenzgeb 2000;138 (3): 240-4.
24. Lew D P, Waldvogel F A. Use of quinolones in osteomyelitis and infected orthopaedic prosthesis. Drugs (58 Suppl 2) 1999: 85-91.
25. Luksa J, Marusic A. Rapid high-performance liquid chromatographic determination of vancomycin in human plasma. J Chromatogr B Biomed Appl 1995; 667: 277-81.
26. Massias L, Dubois C, de Lentdecker P, Brodaty O, Fischler M, Farinotti R. Penetration of vancomycin in uninfected sternal bone. Antimicrob Agents Chemother 1992; 36: 2539-41.
27. Matzke G R, Zhanel G G, Guay D R. Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet 1986; 11: 257-82.
28. Monzon M, Garcia-Alvarez F, Lacleriga A, Amorena B. Evaluation of four experimental osteomyelitis infection models by using precolonized implants and bacterial suspensions. Acta Orthop Scand 2002; 73: 11-9.
29. Mori H, Nakajima T, Nakayama A, Yamori M, Izushi F, Gomita Y. Interaction between levofloxacin and vancomycin in rats - study of serum and organ levels. Chemotherapy 1998; 44: 181-9.
30. Nguyen L L, Nelson C L, Saccente M, Smeltzer M S, Wassell D L, McLaren S G. Detecting bacterial colonization of implanted orthopaedic devices by ultrasonication. Clin Orthop 2002; (403): 29-37.
31. Puolakka T J, Pajamaki K J, Halonen P J, Pulkkinen P O, Paavolainen P, Nevalainen J K. The Finnish Arthroplasty Register: report of the hip register. Acta Orthop Scand 2001; 72: 433-41.
32. Segawa H, Tsukayama D T, Kyle R F, Becker D A, Gustilo R B. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg (Am) 1999; 81: 1434-45.
33. Sharkey P F, Hozack W J, Rothman R H, Shastri S, Jacoby S M. Insall Award paper. Why are total knee arthroplasties failing today? Clin Orthop 2002; (404): 7-13.
34. Siefert H M, Kohlsdorfer C, Steinke W, Witt A. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. J Antimicrob Chemother (43 Suppl B) 1999: 61-7.
35. Silva M, Tharani R, Schmalzried T P. Results of direct exchange or debridement of the infected total knee arthroplasty. Clin Orthop 2002; (404): 125-31.
36. Spangehl M J, Masri B A, O'Connell J X, Duncan C P. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg (Am) 1999a; 81: 672-83.
37. Spangehl M J, Masterson E, Masri B A, O'Connell J X, Duncan C P. The role of intraoperative gram stain in the diagnosis of infection during revision total hip arthroplasty. J Arthroplasty 1999b; 14: 952-6.
38. Vaudaux P, Francois P, Bisognano C, Schrenzel J, Lew D P. Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46: 1503-9.
39. von Baum H, Bottcher S, Abel R, Gerner H J, Sonntag H G. Tissue and serum concentrations of levofloxacin in orthopaedic patients. Int J Antimicrob Agents 2001; 18: 335-40.
40. Vuorisalo S, Pokela R, Satta J, Syrjala H. Internal mammary artery harvesting and antibiotic concentrations in sternal bone during coronary artery bypass. Int J Angiology 2000; 9: 78-81.
41. Wilson K J, Mader J T. Concentrations of vancomycin in bone and serum of normal rabbits and those with osteomyelitis. Antimicrob Agents Chemother 1984; 25: 140-1.